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Figure S1. Glucose response of GLUT2 and non-GLUT2 neurons (related to figure 1). 
(A) Voltage trace showing the absence of response to glucose concentration change in an NTS tdTomato-
negative neuron. G5, glucose 5 mM; G0.5, glucose 0.5 mM.  
(B) Bar graphs summarizing glucose effect on Vm and Rinput on NTS tdTomato-negative neurons (n=5). Data 
are presented as mean ± SEM; n.s., non significant.  
(C) Left, current trace recorded in cell-attached configuration in a NTS tdTomato-positive neuron, and in the 
presence of synaptic inhibitors showing spontaneous action currents firing in 5mM and 0.5mM glucose. Right, 
plot of the firing frequency over time in 10 s bins shows an increase in firing under low glucose. 
(D) Pooled glucose effects on spontaneous firing frequency in cell-attached configuration in the presence of 
inhibitors of synaptic transmission confirms the inhibitory effect of glucose on NTS GLUT2 neurons (n=6). Data 











Figure S2. Glucose-induced currents (related to Figure 2).  
(A) Top, representative current-voltage plots for graded glucose concentrations between 0.5 mM and 5 mM. 
Bottom, plot showing the concentration-dependence of net glucose currents measured at -70 mV relative to 5 
mM glucose (n=5). Data are presented as mean ± SEM.  
(B) Top, current-voltage plot recorded with a high-chloride pipette solution shows a similar shift when changing 
glucose concentration as when recording with low intracellular chloride. Bottom, the current-voltage plot of net 
glucose-induced current obtained with high intracellular chloride is identical to the one recorded with low 
chloride, showing that the glucose-induced current is independent from this ion (n=10). Data are presented as 
mean ± SEM. Red dashed line represents the Goldman-Hodgkin-Katz current equation fit to the data. 
(C) Top, representative current-voltage plots showing the inhibitory effect of quinine on glucose-induced 
current. Bottom, the current-voltage plot of net quinine-inhibited current confirms that this drug blocks GLUT2 
neurons leak K+ channels at rest (n=7). Data are presented as mean ± SEM. Red dashed line represents the 













































Figure S3. Optogenetic activation of GLUT2 neurons (related to figure 6). 
 (A) Plot of the average firing rate of GLUT2 neurons stimulated with 400 ms pulses of blue light for different 
illumination intensities. 
(B) Plot of the average firing rate of GLUT2 neurons stimulated with brief pulses (10 ms) of blue light for 
different laser pulse rates.  











Table S1. Intrinsic properties of NTS Glut2+ neurons (related to figure 1) 
Property Glut2+ neurons 
 (n=32) 
Passive membrane properties 
     Resting membrane potential, mV –70.2 ± 1.0 
     Input resistance, Mȍ  738.2 ± 88.5 
     Membrane capacitance, pF  28.5 ± 2.6 
Single action potential properties 
     Amplitude, mV  66.9 ± 1.6 
     Duration, ms 2.2 ± 0.2 
     fast AHP, mV 16.6 ± 1.5 
     Threshold, mV –40.3 ± 1.0 
Discharge properties 
     F-I slope, Hz.pA-1 0.34 ± 0.04 
     Accommodation index 0.59 ± 0.05 
Values are means ± s.e.m. AHP, afterhyperpolarization; F-I, frequency-











Table S2. Glucose effect on action potential properties (related to figure 1)
Property Glucose 5 mM Glucose 0.5 mM 
 (n=12) 
    
Single action potential properties 
     Threshold, mV –39.8 ± 2.1 –38.4 ± 2.0 
     Amplitude, mV  71.0 ± 2.3  70.4 ± 2.7 
     Duration, ms 2.3 ± 0.3 2.3 ± 0.2 
     fast AHP amplitude, mV 14.5 ± 2.9 14.9 ± 3.0 
     fast AHP FWHM, ms 8.3 ± 1.6 8.4 ± 1.5 
Discharge properties 
     Accommodation index 0.59 ± 0.06 0.63 ± 0.06 
    
Values are means ± s.e.m. AHP, afterhyperpolarization; FWHM, full width at 
half maximum. Significance: comparison between columns with 2-tailed paired 













All experimental procedures were carried out according to the Ordinance on Animal Experimentation 
and approved by the veterinary office of Canton de Vaud. Glut2-Cre mice (Mounien et al., 2010) were 
crossed with Rosa26tdTomato reporter mice (Ai9 strain) (Madisen et al., 2010). Offsprings (P14-P23) 
were anesthetized with pentobarbital and decapitated. Sagittal slices of brainstem, 200 Pm thick, 
containing NTS were cut in ice-cold extracellular solution with 10 mM glucose using a vibratome 
(VT1000, Leica Microsystems, Heerbrugg). Slices were subsequently maintained in an incubation 
chamber filled with the slicing extracellular solution at room temperature (22–24°C) and used 
between 1h and 8h after sectioning.  
Electrophysiology 
Experiments were done on an LSM510 Meta confocal microscope (Carl Zeiss, Feldbach, 
Switzerland) mounted on an upright Axioskop FS2 Plus stand and equipped with a motorized stage 
and micromanipulators (Luigs and Neumann, Ratingen, Germany) controlled by computer software 
(kindly provided by Rodrigo Perin and Henri Markram, Laboratory of Neural Microcircuitry, EPFL, 
Lausanne).  
Slices were placed in a submerged-type recording chamber (volume ~ 2 ml) and continuously 
superfused at a flow rate of 2 ml/min with extracellular solution at room temperature (22–24°C). NTS 
boundaries were set under a low-power objective with infrared differential interference contrast 
illumination. A 40x/0.8 water dipping objective was then used to localize tdTomato-expressing 
neurons with confocal epifluorescence microscopy.  
Borosilicate glass pipettes with tip resistances ranging from 4 to 5 Mȍ where used to obtain whole-
cell recordings from visually identified neurons. Recordings were performed with a Multiclamp 700B 
amplifier (Molecular Devices). Bridge balance and pipette capacitance were adjusted. Signals were 
low-pass filtered at 3 KHz, sampled at 10 KHz with a Digidata 1440 A/D interface (Molecular 
Devices), and acquired with pClamp 10 software package (Molecular devices). Cells were held at -70 
mV in voltage clamp and with no bias current injection in current-clamp. Cells for which access 
resistance was above 30 M:or changed by more than 20% during the recording were discarded. A 
settling time of  10 min was observed after break-through before starting measurements. Continuous 
recordings of membrane potential were used to monitor the effect of glucose and of metabolically-
active drugs. Recordings where resting membrane potential was not stable over time or where the 
effect of glucose concentration change on resting membrane potential was not reversible were 











input resistance. The continuous recording was paused when the effect of each experimental 
condition had reached a plateau to carry out additional measurements of passive and active 
membrane properties.  
Cell attached recordings were performed on slice superfused with a modified extracellular solution to 
favor spontaneous firing (Dani et al., 2005) with patch pipettes filled with extracellular solution. Action 
current firing frequency was measured in voltage-clamp mode with a command voltage leading to a 
holding current of 0 pA.  
Solutions and drugs 
The standard extracellular solution contained (mM): 125 NaCl, 2.5 KCl, 26 NaHCO3, 1.25 NaH2PO4, 2 
CaCl2, 1 MgCl2 and 5 D-glucose. Modified extracellular solution used for cell-attached recording 
contained (mM): 126 NaCl, 3.5 KCl, 25 NaHCO3, 1 NaH2PO4, 1 CaCl2, 0.5 MgCl2 and 5 D-glucose. 
Extracellular solutions made with lower glucose concentrations had sucrose added to compensate for 
the change in osmolarity. 
Whole-cell recordings were done with a pipette solution containing (mM): 130 K-gluconate, 2 NaCl, 1 
MgCl2, 10 Hepes, 0.1 EGTA, 10 sodium phosphocreatine, 4 MgATP, 0.5 Na2GTP. Where mentioned, 
a high-chloride pipette solution was used and contained (mM): 130 KCl, 15 K-gluconate, 2 NaCl, 1 
MgCl2, 10 Hepes, 0.1 EGTA, 10 sodium phosphocreatine, 4 MgATP, 0.5 Na2GTP. In recordings 
performed to check the dependency of glucose-induced effect on intracellular glucose processing, 3 
mM of glucose was added to the standard pipette solution. We established that this concentration 
was sufficient to saturate intracellular glucose metabolism while enabling the effect of competitive 
glucokinase inhibitor D-glucosamine. Biocytin (0.5% w/v) was added to the pipette solution in the 
cases where we wanted to trace axonal projections with immunohistochemistry. All pipette solutions 
were adjusted to pH 7.3 with KOH. 
In experiments where we wanted to block network-dependent effects, we added the following 
synaptic blockers to the extracellular solution: 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX, 20 ȝM, 
AMPA glutamate receptor antagonist), D-aminophosphonovalerate (D-AP5, 50 ȝM, NMDA glutamate 
receptor antagonist), bicuculline (20 ȝM, GABAA receptor antagonist), strychnine hydrochloride (1 ȝM,
glycine receptor antagonist). During continuous recordings of glucose-induced currents we blocked 
network activity by adding tetrodotoxin citrate (TTX, 1 ȝM, voltage-gated sodium channel antagonsist). 
In addition, the following drugs were added to the extracellular solution were mentioned: Quinine (200 
PM, leak potassium channel blocker), 2-deoxyglucose (2-DG, 10 mM, metabolic inhibitor), D-











mitochondrial ATPase), 5-amino-4-imidazolecarboxamide riboside (AICAR 500 PM, AMPK allosteric 
activator), Compound C (150 PM, AMPK inhibitor). 
CNQX, D-AP5 and bicuculline were from Ascent Scientific (Cambridge, UK). TTX was from Biotrend 
(Anawa, Wangen, Switzerland). Strychnine hydrochloride, quinine hydrochloride, AICAR and 
compound C were from Tocris Bioscience (R&D Systems Europe, Abingdon, UK). Oligomycine, D-
glucosamine and 2-deoxyglucose were from Sigma (Sigma-Aldrich, Buchs, Switzerland). 
Data analysis 
Electrophysiological data were analyzed with pClamp 10 (Molecular Devices). Data were corrected 
for calculated liquid junction potentials. Input resistance was monitored in current-clamp mode by 
periodic by 500 ms hyperpolarizing current pulses and calculated according to Ohm’s law as the ratio 
of the voltage deflection measured at steady state over the intensity of the current pulse. For cell 
attached recordings, action currents were detected by template matching and firing rate was 
subsequently calculated over 10 s bins. Values of resting membrane potential, input resistance and 
firing rate obtained from continuous traces were plotted over time in Excel (Microsoft) and effects of 
glucose and drugs on these parameters were measured as averages over 1 min at the plateau of 
effect.  
Current–voltage relationships (IV curves) were obtained by measuring steady state currents during 
successive hyperpolarizing and depolarizing voltage steps from the holding potential. Net glucose 
current IV curves, obtained by subtracting current values measured at 0.5 mM glucose from those 
measured at 5 mM glucose, were fitted by the Goldman-Hodgkin-Katz current equation (Hille, 2001).  
Frequency-intensity curves (FI curves) were established by measuring the discharge frequency for 
depolarizing current steps of increasing intensities. The gain of FI curve was computed as the slope 
of the fit to the linear part of the FI curve. The rheobase was measured as the current intensity 
eliciting the first action potential during a slowly rising current ramp.  
Single action potential (AP) properties were measured on the first AP elicited by near-threshold 
depolarizations. The AP threshold was calculated as the membrane potential at which its first 
derivative reached 10 mV msí1. AP duration was the time for membrane potential to return to the 
threshold value. Amplitudes of the AP and of the fast afterhyperpolarization (fast AHP) were 
determined from threshold. The discharge response to a 2 s current step was used to establish the 
firing pattern. The accommodation index was quantified as the ratio between the first and the last 











Group data were presented as averages ± s.e.m. Statistical inference testing was performed with 
paired and unpaired 2-tailed Student’s t tests.  Differences were considered significant for p < 0.05. 
Statistical analysis and curve fitting were done with Origin 8.5 (OriginLab).  
Single cell RT-PCR 
For single-cell transcripts amplification, RNAse-free pipette solution and patch pipettes were prepared. 
The silver wire was rechlorinated just before the experiment. Whole-cell configuration was 
established. At the end of the recording, the cytosol was slowly aspirated under visual control by 
applying gentle negative pressure to the pipette. Negative pressure was removed and the pipette was 
carefully withdrawn to avoid contamination. 
The aspirated single-cell content was expelled into the RNase free PCR tube containing 0.5 Pl
RNasin (40 U/Pl; Promega), 1 PL random primer (0.5 Pg/Pl; Invitrogen), and 0.5 Pl of 20 mM dNTPs.  
It was incubated at 70 °C for 5 min and 4 °C for 10 min. Then 4 Pl of 5x First Strand Buffer 
(Invitrogen), 1 Pl of 0.1 M DTT, 0.5 Pl of RNasin, and 0.5 Pl of Reverse Transcriptase superscript II 
(200U/Pl; Invitrogen) were added for reverse transcription and incubated at 37 °C for 60 min. This 
was followed by heat inactivation at 70 °C for 10 min and incubation at 4 °C for 10 min. 
The PCR conditions were optimized for each gene. We performed two successive PCR rounds. The 
first round of PCR used the cDNAs present in the reverse transcription reaction as a template, 
complemented with 2 Pl of each 10 PM primers, 1 Pl of 20 mM dNTPs, 1 Pl of HotStart Taq plus DNA 
polymerase (5 U/Pl; Qiagen) in a final volume of 50 Pl.  For the second round of PCR, 10 Pl of the first 
PCR product were used as template with addition of 0.4 Pl of each 10 PM primers, 0.4 Pl of 20 mM 
dNTPs, and 0.1 Pl of KAPA 2G Fast DNA polymerase (5 U/Pl; KAPA Biosystems) final volume of 20 
Pl. The products of the second PCR product were analyzed in agarose gel using ethidium bromide. 
PCR primers used for Glut2 were : forward 5’-TGC TTC CAG TAC ATT GCG GA-3’ and reverse 5’-
TGA TAT TTC TAA TCG GAG TC-3’ (amplicon size 364 bp) and for beta actin: forward 5’-GCC AAC 
CGT GAA AAG ATG AC-3’ and 5’-GCA CTG TGT TGG CAT AGA GG3’(amplicon size 560 bp). 
Immunohistochemistry 
To study the co-localization of GLUT2 with neuronal markers GAD67 and parvalbumin (PV), pAMPKD
Glut2-Cre/tdTomato mice were perfused with 4% paraformaldehyde. The brains were removed, 











prepared.  Sections were washed with PBS, blocked with 0.1 % TritonX-100/10% NGS in PBS 3 h 
and incubated with primary antibodies against GAD67 (MAB5406, Chemicon, Temecula, CA, USA, 
1:500), PV (PV235, Swant, Bellinzona, Switzerland, 1:1000) or pAMPKD (ab2535, Cell Signalling 
Technology, Danvers, MA, 1:200) in 0.1% TritonX-100/3% NGS/PBS overnight. They were then 
incubated with a FITC-coupled secondary antibody diluted 1:100 in 3% NGS/PBS for 3 h, washed, 
mounted on glass slides and coverslipped with Vectashield (Vector H-1000) mounting medium.  
To investigate the interaction of NTS GLUT2 neurons with DMNX cells, we filled tdT+ neurons during 
whole-cell recording with a pipette solution containing 0.5% (w/v) biocytin for  20 min to allow the 
marker to diffuse to distal cell processes. After recording, slices were fixed with PFA 4% at +4°C 
overnight. A set a slices with no biocytin-filled cells were also processed. All slices were rinsed with 
PBS, incubated in a permeabilizing solution containing 10% NGS and 0.5% triton X-100 for 5h in PBS 
at room temperature and transferred to PBS containing a mouse monoclonal antibody against choline 
acetyltransferase (ab35948, Abcam, 1:300) at +4°C for 3 days. After further rinsing in PBS, slices 
were incubated in PBS containing an anti-mouse antibody coupled to AlexaFluor647 (A21235, 
Invitrogen, 1:200) and Cascade Blue-Neutravidin (A2663, Invitrogen, 1:100) overnight. After final 
rinsing, slices were mounted on glass slides and coverslipped with Vectashield (Vector H-1000) 
mounting medium.  
Image acquisition and processing 
Confocal images of immunostained cryosections were taken on a LSM 510 Meta confocal 
microscope with a 40x1.3 N.A. oil immersion objective (Carl Zeiss, Feldbach, Switzerland), with the 
appropriate excitation beams and filter sets. Stacks were acquired (512x512 pixels, 4 times 
averaging) with a step size of 0.6 mm and processed with Image J (Rasband, W.S., NIH, Bethesda, 
Maryland, USA, http://imagej.nih.gov/ij/) to obtain maximum intensity projection representations. The 
absence of cross-talk between imaging channels was checked by acquiring separate image sets for 
each of the excitation beams individually.    
Confocal images of recorded slices were taken on a LSM 710 Quasar confocal microscope (Carl 
Zeiss, Feldbach, Switzerland). A 20x0.5 N.A. dry objective was used to acquire juxtaposed stacks 
covering the whole dorsal vagal complex area to visualize the recorded cell and it axonal projections. 
Further images were taken with a 63x/1.4 N.A. oil immersion objective to get high resolution stacks 
(1024x1024, 4 times averaging, 0.2 mm z step size) of biocytin-filed axonal projections in DMNX. 
These images were 3D reconstructed and represented as maximum intensity projections with Imaris 












Glut2-Cre mice (Mounien et al., 2010) were crossed with Rosa26ChR2-YFP reporter mice (Ai32 
strain) (Madisen et al., 2012). Acute brain slices were prepared from offspring (P14-P23) as 
described above to perform electrophysiological recordings from NTS ChR2-expressing neurons. 
These cells were targeted thanks to the co-expression of YFP with ChR2 and recorded by whole-cell 
patch-clamp (see above). Light stimulation was achieved with an optical fiber coupled to a laser 
source (473 nm, Rapp Optoelectronics, Wedel, Germany) and brought close to the recorded cell with 
a micromanipulator. Light pulses were triggered by a custom-made electrical stimulus generator 
controlled by the electrophysiology software (pClamp).  
For in vivo experiments, Glut2-Cretg/+xChR2tg/+ mice and Glut2-Cre+/+xChR2tg/+ littermates were 
anesthetized with isoflurane and placed on a heating blanket to maintain the body temperature at 
37.0 ± 0.2°C. Open access to the caudal brainstem was obtained after dissecting the neck muscles in 
the midline and removing the tentorium cerebelli. The neck was sharply flexed to enable access to 
the more rostral portions of the NTS (Berthoud et al., 1990). An optical fiber (200 Pm diameter core, 
NA 0.48) coupled to a laser source (473 nm, Rapp Optoelectronics, Wedel, Germany) was attached 
to a stereotaxic micromanipulator and positioned above the NTS. The light stimulus was delivered for 
40 min with a protocol that was shown to elicit neuronal firing in vitro (10-15 mW, 10 ms pulses at 20 
Hz for 1s every 4s). Activity of the vagus nerve was continuously recorded for 10 min before, during 
and for 10 min after photostimulation as previously described (Magnan et al., 1999). Brieflly, the 
vagus was exposed along the carotid artery to attach a silver-wire recording electrode (0.6-mm 
diameter) connected to a high-impedance probe. A second electrode was implanted under the skin as 
a reference. Action potentials were amplified with a low-noise amplifier (BIO amplifier, AD Instrument, 
Oxford, UK; Gain:105), band-pass filtered (100-1000 Hz), digitized (PowerLab 16/35 digitizer, AD 
Instrument, Oxford, UK) and acquired with the LabChart 7 software (AD Instrument, Oxford, UK). 
Nerve activity was analyzed with LabChart 7 and resulting data compared with 2-way nova followed 
by Bonferroni post-hoc tests. Glucagon was quantitated by radioimmunoassay (Linco Research Inc.) 
at the end of experiment in plasma prepared from blood sampled by intracardiac puncture in the 
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